Adlai Nortye Ltd. ( ANL) - Stock Earnings
ANL Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 17, 2026, midnight | — / — | — | — / — | — |
ANL Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -8.6 million USD | 2.5 million USD |
| 2026Q1 | -2.7 million USD | 7.3 million USD |
| 2026Q2 | -2.7 million USD | 7.3 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
ANL Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -109.2 million USD | 5.0 million USD |
| 2024 | -51.9 million USD | — USD |
| 2025 | -35.5 million USD | 5.0 million USD |
| 2026 Est. | — | — |
ANL
Price: $13.72
52 week price:
Earnings Per Share: -0.66 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 922.8 million